A heavily cited randomized comparative trial by Vermeulen et al
The more clinically relevant question is whether controlled glucagon receptor activation, when paired with GLP-1 and/or GIP receptor agonism, can shift glucagons metabolic impact from primarily hyperglycemic toward thermogenic, lipolytic, and hepatometabolic benefit
But they manage it effectively, providing immediate relief and protecting tissues that would otherwise be exposed
Major medical organizations do not endorse growth hormone or its secretagogues for anti-aging
Hair shedding has been reported during treatment and appears associated with weight reduction, not direct damage to hair follicles
The transition should be guided by a healthcare provider who can review dosing, symptoms, labs and overall treatment response